December 10, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, today announced it will commence the full U.S. commercial launch of TACTOSET, its surgically delivered therapy for bone repair procedures, at the Orthopaedic Summit 2019: Evolving Techniques (OSET), …